Silo Pharma (SILO) Change in Acquisitions & Divestments (2020 - 2025)
Silo Pharma (SILO) posted Change in Acquisitions & Divestments of $410300.0 for Q2 2025, down 54.68% sequentially from $905353.0 in Q1 2025, and down 58.93% YoY from $998931.0 in Q2 2024.
Silo Pharma (SILO) Change in Acquisitions & Divestments (2020 - 2025) Analysis & Trends
Silo Pharma has reported Change in Acquisitions & Divestments for 5 years, with the latest figure at $410300.0 in Q2 2025.
- Quarterly Change in Acquisitions & Divestments fell 58.93% year-over-year to $410300.0 in Q2 2025, while the trailing twelve-month figure through Dec 2025 was $1.3 million (up 14.47% YoY) and the FY2025 annual result came in at $1.3 million, up 14.47% from the prior year.
- Change in Acquisitions & Divestments declined to $410300.0 in Q2 2025 per SILO's latest filing, from $905353.0 in the prior quarter.
- Over five years, Change in Acquisitions & Divestments peaked at $1.4 million in Q3 2023 and troughed at -$62000.0 in Q3 2021.
- A 4-year average of $480717.1 and a median of $280344.5 in 2024 frame the typical range for Change in Acquisitions & Divestments.
- The sharpest annual moves came in 2021 and 2025: Change in Acquisitions & Divestments plunged 1340.0% in 2021, then jumped 502.01% in 2025.
- Over 4 years, Change in Acquisitions & Divestments stood at -$62000.0 in 2021, then jumped by 2314.94% to $1.4 million in 2023, then slipped by 27.26% to $998931.0 in 2024, then plunged by 58.93% to $410300.0 in 2025.
- According to Business Quant data, Change in Acquisitions & Divestments over the past three periods registered $410300.0, $905353.0, and $998931.0 for Q2 2025, Q1 2025, and Q2 2024 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Silo Pharma | 2.92 Mn | 2.92 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 410,300.00 |
| Jun 30, 2025 | 410,300.00 |
| Mar 31, 2025 | 905,353.00 |
| Mar 31, 2025 | 905,353.00 |
| Jun 30, 2024 | 998,931.00 |
| Jun 30, 2024 | 998,931.00 |
| Mar 31, 2024 | 150,389.00 |
| Mar 31, 2024 | 150,389.00 |
| Sep 30, 2023 | 1.37 Mn |
| Sep 30, 2023 | 1.37 Mn |
| Sep 30, 2021 | -62,000.00 |
| Sep 30, 2021 | -62,000.00 |
| Jun 30, 2021 | 62,000.00 |
| Jun 30, 2021 | 62,000.00 |
| Mar 31, 2021 | 7,500.00 |
| Mar 31, 2021 | 7,500.00 |
| Dec 31, 2020 | 19,000.00 |
| Dec 31, 2020 | 19,000.00 |
| Sep 30, 2020 | 5,000.00 |
| Sep 30, 2020 | 5,000.00 |